HLB BioStep Co

HLB BioStep Co EBIT per Share

The EBIT per Share of HLB BioStep Co (278650.KQ) as of Oct 9, 2026 is -510.03 KRW. In the previous year, EBIT per Share was -152.10 KRW — a change of 235.33% (lower).

EBIT per Share

-510.03KRW

YoY

235.33%

Last updated:

EBIT per Share of HLB BioStep Co is 2025 -510.03 KRW. EBIT per Share of HLB BioStep Co was 2024 -152.10 KRW. It decreases by 235.33% lower compared to the previous year.

The HLB BioStep Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
97.33 KRW
Jan 1, 2019
102.24 KRW
Jan 1, 2020
130.20 KRW
Jan 1, 2021
198.20 KRW
Jan 1, 2022
71.81 KRW
Jan 1, 2023
28.79 KRW
Jan 1, 2024
-152.10 KRW
Jan 1, 2025
-510.03 KRW
The HLB BioStep Co EBIT per Share history
YEAREBIT per ShareYoY
-510.03KRW+235.33%
-152.10KRW-628.21%
28.79KRW-59.90%
71.81KRW-63.77%
198.20KRW+52.22%
130.20KRW+27.35%
102.24KRW+5.04%
97.33KRW+11.96%
86.94KRW+19.08%
73.01KRW—
Access this data via the Eulerpool API
Get Free API Key

HLB BioStep Co Stock analysis

What does HLB BioStep Co do? HLB BioStep Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about HLB BioStep Co stock

EBIT per Share of HLB BioStep Co is -510.03 KRW in 2025.

EBIT per Share of HLB BioStep Co changed from -152.10 KRW to -510.03 KRW, representing a 235.33% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share HLB BioStep Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — HLB BioStep Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — HLB BioStep Co